1601465-90-0Relevant academic research and scientific papers
Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)
Sch?fer, Anja,Burstein, Ethan S.,Olsson, Roger
, p. 1944 - 1947 (2014)
Bexarotene, a retinoid X receptor (RXR) agonist, is being tested as a potential disease modifying treatment for neurodegenerative conditions. To limit the peripheral exposure of bexarotene and release it only in the affected areas of the brain, we designe
